Japanese approve payments for Boston's stent:
This article was originally published in Clinica
Boston Scientific's NIR w/SOX stent system will go on sale in Japan this quarter now that it has received approval for marketing and reimbursement. Two versions of the stent system, over-the-wire and Monorail (rapid exchange), were approved. The Monorail device will be launched later this year.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.